Effects of Losartan on Insulin Resistance in Patients With Heart Failure
NCT00663377 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 16
Last updated 2008-04-22
Summary
The purpose of this study is to evaluate the effects of losartan, an ARB, on glucose metabolism and inflammatory cytokines in CHF patients treated with ACE inhibitors.
Conditions
Interventions
- DRUG
-
losartan
losartan 50-100mg for 16 weeks
Sponsors & Collaborators
-
Tottori University Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-04-30
- Completion
- 2007-03-31
More Related Trials
-
Initiation of ARNi and SGLT2i in Patients With HFrEF
NCT05989503 ·Status: COMPLETED ·Phase: PHASE4
-
A Morbidity-Mortality and Remodeling Study With Valsartan
NCT00133328 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Sodium Glucose Cotransporter 2 Inhibitiors on Left Ventricular Remodeling Among Diabetic and Non Diabetic Patients With Chronic Heart Failure
NCT06137430 ·Status: NOT_YET_RECRUITING
-
Comparison of Long- and Short-acting Diuretics in Congestive Heart Failure
NCT00355667 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy and Safety of Tofacitinib in Patients With Glucocorticoid Resistant ICIs-related Myocarditis
NCT06393972 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Empagliflozin on the Function of Left Atrium in Heart Failure With Mildly Reduced or Preserved Ejection Fraction
NCT05600387 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
NCT02924727 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Losartan in Patients With Nonobstructive Hypertrophic Cardiomyopathy
NCT01150461 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Compare the Effects of Two Dosages of Tolvaptan in Congestive Heart Failure Patients
NCT00043771 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I/II Clinical Study of SK&F-105517-D in Japanese Patients With Chronic Heart Failure
NCT00742508 ·Status: COMPLETED ·Phase: PHASE1
-
Sacubitril-valsartan in Patients With Heart Failure With Reduced Ejection Fraction From Rural Tanzania
NCT06704633 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients
NCT01922089 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of an Intravenous Solution of JNJ-39588146 or Placebo in Patients With Heart Failure
NCT01120210 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Use of Empagliflozin in Patients with HF with PEF in a Cardiology Outpatient Department
NCT06683053 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Research Study on the Effects of NNC0537-1482 in Healthy Individuals When Injected Under the Skin
NCT06625307 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Tolvaptan on Mid- to Long-term Prognosis of Heart Failure Patients
NCT01439009 ·Status: COMPLETED ·Phase: PHASE4
-
The Comparative Effectiveness Between ARNI and ACE Inhibitor/ARB Medication in Patient With HFrEF
NCT05329727 ·Status: RECRUITING
-
Dose-comparison Study of Prednisone in Heart Failure
NCT01559727 ·Status: COMPLETED ·Phase: PHASE3
-
Defining the Role of Insulin Resistance in 'Idiopathic' Dilated Cardiomyopathy
NCT00466713 ·Status: TERMINATED ·Phase: NA
-
Safety/Tolerability, Pharmacokinetics/Pharmacodynamics (PK/PD) of LCZ696 in Patients With Stable Heart Failure
NCT00913653 ·Status: COMPLETED ·Phase: PHASE2
-
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
NCT01035255 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluation of the Effect of Injectable Neucardin on Cardiac Function and Reversal Ventricular Remodeling in Patients With Chronic Systolic Heart Failure
NCT05949801 ·Status: COMPLETED ·Phase: PHASE3
-
Phase II Clinical Study of HRS-9057 Injection in Patients With Heart Failure-induced Fluid Retention
NCT07318103 ·Status: RECRUITING ·Phase: PHASE2
-
ERtugliflozin triAl in DIabetes With Preserved or Reduced ejeCtion FrAcTion mEchanistic Evaluation in Heart Failure
NCT03416270 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure
NCT03036124 ·Status: COMPLETED ·Phase: PHASE3